Revisiting immune checkpoint inhibitors: new strategies to enhance efficacy and reduce toxicityDianying Zhang, Dan Liu, Hongfei Jiang et al.|Frontiers in Immunology|2024Cited by 30
Prognostic Impact of PCK1 Protein Kinase Activity-Dependent Nuclear SREBP1 Activation in Non-Small-Cell Lung CarcinomaFei Shao, Zhimin Lu, Daqian Xu et al.|Frontiers in Oncology|2021Cited by 18
Gut microbiota-mediated berberine metabolism ameliorates cholestatic liver disease by suppressing 5-hydroxytryptamine productionDianji Tu, Shiming Yang, Yunxuan Feng et al.|Clinical and Molecular Hepatology|2025Cited by 6